| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $81.2M | -3.8% |
| Cost of Revenue | $58.8M | +8.4% |
| Gross Profit | $22.4M | -25.8% |
| R&D Expense | $14.6M | +25.2% |
| SG&A Expense | $18.1M | +40.6% |
| Operating Income | -$17.3M | -543.9% |
| Pre-tax Income | -$16.5M | -772.9% |
| Income Tax | $10.7M | +1590.9% |
| Net Income | -$27.2M | -1586.7% |
| EPS (Basic) | -$0.73 | -1560.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.6M | +17.3% |
| Current Assets | $31.1M | -0.6% |
| Total Assets | $59.3M | -4.6% |
| Current Liabilities | $49.8M | +37.7% |
| Long-term Debt | $14.6M | +154.3% |
| Total Liabilities | $81.2M | +39.9% |
| Stockholders' Equity | -$16.4M | -269.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.2M | +26.3% |
| Capital Expenditures | $16K | — |
| Investing Cash Flow | -$5.3M | — |
| Financing Cash Flow | $8.7M | +234.2% |
| Free Cash Flow | -$1.2M | — |